Comparison of PFS and safety for Asian compared to North American and European populations in the phase III trial of pazopanib versus sunitinib in patients with treatment-naive RCC (COMPARZ) Meeting Abstract


Authors: Guo, J.; Jin, J.; Huang, Y.; Wang, J. W.; Lim, H. Y.; Uemura, H.; Rha, S. Y.; Wu, H. C.; Crescenzo, R.; Deen, K. C.; McCann, L.; Motzer, R. J.
Abstract Title: Comparison of PFS and safety for Asian compared to North American and European populations in the phase III trial of pazopanib versus sunitinib in patients with treatment-naive RCC (COMPARZ)
Meeting Title: 2013 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 6 Suppl.
Meeting Dates: 2013 Feb 14-16
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-02-20
Language: English
ACCESSION: WOS:000333679600364
DOI: 10.1200/jco.2013.31.6_suppl.366
PROVIDER: wos
Notes: Meeting Abstract: 366 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer